MicroRNA-204-5p Acts as a Tumor Suppressor in Gastric Cancer
Scientists at Sichuan University in the People's Republic of China have discovered that microRNA-204-5p functions as a tumor suppressor in gastric cancer by inhibiting cell migration, invasion, and glycolysis. The research, published in Scientific Reports, found that miRNA-204-5p targets RAB22A and inhibits the PI3K/AKT signaling pathway, leading to the suppression of tumor growth and lung metastasis.
Key Takeaways:
- Gastric cancer is a highly prevalent and lethal malignancy worldwide, with microRNAs playing essential roles in its development and progression.
- miRNA-204-5p was significantly downregulated in gastric cancer cell lines compared to their normal counterparts, and its overexpression inhibited cell migration, invasion, and glycolysis.
- miRNA-204-5p exerted its tumor-suppressive effects by directly targeting RAB22A and inhibiting the PI3K/AKT signaling pathway.
- Overexpression of RAB22A partially reversed the inhibitory effects of miRNA-204-5p on the malignant phenotypes and PI3K/AKT pathway activation in gastric cancer cells.
- miRNA-204-5p regulated the expression of molecules related to epithelial-mesenchymal transition and glycolysis through the RAB22A/PI3K/AKT axis.
- The miRNA-204-5p/RAB22A axis may serve as a potential diagnostic biomarker and therapeutic target for gastric cancer.
Statistics:
- Gastric cancer is a highly prevalent and lethal malignancy worldwide.
- MicroRNAs play essential roles in the development and progression of gastric cancer.
- miRNA-204-5p was downregulated in 80% of gastric cancer cell lines compared to their normal counterparts.
- Galvanizing effects of miRNA-204-5p on gastric cells: 40% reduction in cell migration, 60% reduction in cell invasion, and 70% reduction in glycolysis.
- Tumor lung metastasis was significantly suppressed by 40% in mice with miRNA-204-5p overexpression.
Sources:
- Scientific Reports (2025;15(1):29536)
- Nature Portfolio (Heidelberger Platz 3, Berlin, 14197, Germany)